Wird geladen...
CMET-36. BEVACIZUMAB WITH OR WITHOUT LOMUSTINE FOR METASTATIC ORBITAL, DURAL AND LEPTOMENINGEAL ESTHESIONEUROBLASTOMA
Esthesioneuroblastoma is a malignant neuroectodermal tumor originating from the olfactory neuroepithelium. Bevacizumab is a specific inhibitor of the vascular endothelial growth factor ligand, preventing its interaction with receptors on endothelial cells. Lomustine is a widely used alkylating agent...
Gespeichert in:
| Veröffentlicht in: | Neuro Oncol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216982/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.246 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|